Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages

British Journal of Pharmacology

Volumn 128, Issue 2, 1999, Pages 380-384

  Kang, B Y ^a   Song, Y J ^a   Kim, K M ^a   Choe, Y K ^b   Hwang, S Y ^c   Kim, T S ^a  

^a Chonnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Curcumin; Cytokine profile; Interleukin 12; Macrophage; T helper cell

Indexed keywords

CD4 ANTIGEN; CURCUMIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; CURCUMA LONGA; CYTOKINE PRODUCTION; HELPER CELL; LISTERIA MONOCYTOGENES; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CD4-POSITIVE T-LYMPHOCYTES; CURCUMIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LISTERIA MONOCYTOGENES; MACROPHAGES; MICE; MICE, INBRED DBA; TH1 CELLS;

EID: 0032883350     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702803     Document Type: Article

References (31)

1. ALLEN, P.C., DANFORTH, H.D. & AUGUSTINE, P.C. (1998). Dietary modulation of avian coccidiosis. Int. J. Parasitol., 28, 1131-1140.
2. BENJAMIN, D., SHARMA, V., KUBIN, M., KLEIN, J.L., SARTORI, A., HOLLIDAY, J. & TRINCHIERI, G. (1996). IL-12 expression in AIDS-related lymphoma B cell lines. J. Immunol., 156, 1626-1637.
3. BRENNAN, P. & O'NEILL, L.A. (1998). Inhibition of nuclear factor κB by direct modification in whole cells mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem. Pharmacol., 55, 965-973.
4. CASPI, R.R. (1998). IL-12 in autoimmunity. Clin. Immunol. Immunopathol., 88, 4-13.
5. CHAN, M.M., HUANG, H.I., FENTON, M.R. & FONG, D. (1998). In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol., 55, 1955-1962.
6. + T cell responses: the alternative approaches. Annu. Rev. Immunol., 15, 297-322.
7. + lymphocytes by inhibiting IL-12 production. J. Immunol., 160, 2231-2237.
8. D'ELIOS, M. & DEL PRETE, G. (1998). Th1/Th2 balance in human disease. Transplant Proc., 30, 2373-2379.
9. FLSE, K.J. & FINKELMAN, F.D. (1998). Intestinal nematode parasites, cytokines and effector mechanisms. Int. J. Parasitol., 28, 1145-1158.
10. GATELY, M.K., RENZFTTI, L.M., MAGRAM, J., STERN, A.S., ADORINI, L., GUBLER, U. & PRESKY, D.H. (1998). The interleukin-12 interleukin-12-receptor system: role in normal and pathologie immune responses. Annu. Rev. Immunol., 16, 495-521.
11. + T cell clones for high production of both interferon-gamma and interleukin-10. J. Exp. Med., 183, 2559-2569.
12. GESCHER, A., PASTORINO, U., PLUMMER, S.M. & MANSON, M.M. (1998). Suppression of tumour development by substances derived from the diet-mechanisms and clinical implications. Br. J. Clin. Pharmacol., 45, 1-12.
13. GREWE, M., BRUIJNZEEL-KOOMEN, C.A., SCHOPF, E., THEPEN, T., LANGEVELD-WILDSCHUT, A.G., RUZICKA, T. & KRUTMANN, J. (1998). A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today, 19, 359-361.
14. HAYASHI, M., MARTINEZ, O.M., GARCIA-KENNEDY, R., SO, S., ESQUIVEL, C.O. & KRAMS, S.M. (1995). Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation, 60, 1533-1538.
15. KANG, K., KUBIN, M., COOPER, K.D., LESSIN, S.R., TRINCHIERI, G. & ROOK, A.H. (1996), IL-12 synthesis by human Langerhans cells. J. Immunol., 156, 1402-1407.
16. KIM, T.S., DEKRUYFF, R.H., RUPPER, R., MAECKER, H.T., LEVY, S. & UMETSU, D.T. (1997). An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J. Immunol., 158, 4137-4144.
17. LAFAILLE, J.J. (1998). The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev., 9, 139-151.
18. LAWRENCE, C. & NAUCIEL, C. (1998). Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan. Infect. Immun., 66, 4947-4949.
19. + T lymphocytes. J. Immunol., 155, 111-117.
20. MAZUMDER, A., WANG, S., NEAMATI, N., NICKLAUS, M., SUNDER, S., CHEN, J., MILNE, G.W., RICE, W.G., BURKE JR T.R. & POMMIER, Y. (1996). Antiretroviral agents as inhibitors of both human immunodeficiency virus type I integrase and protease. J. Med. Chem., 39, 2472-2481.
21. MOSMANN, T.R. (1991). Cytokine secretion phenotypes of TH cells: how many subsets, how much regulation? Res. Immunol., 142, 9-13.
22. NA, S.-Y., KANG, B.Y., CHUNG, S.W., HAN, S.-J., MA, X., TRINCHIERI, G., IM, S.-Y., LEE, J.W. & KIM, T.S. (1999). Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NF κ B. J. Biol. Chem., 274, 7674-7680.
23. O'GARRA, A. (1998). Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity, 8, 275-283.
24. PANINA-BORDIGNON, P., MAZZEO, D., LUCIA, P.D., D'AMBROSIO, D., LANG, R., FABBRI, L., SELF, C. & SINIGAGLIA, F. (1997). β2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest., 100, 1513-1519.
25. ROMAGNANI, S. (1996a). Th1 and Th2 in human diseases. Clin Immunol. Immunopathol., 80, 225-235.
26. ROMAGNANI, S. (1996b). Development of Th1- or Th2-dominated immune responses: what about the polarizing signals? Int. J. Clin. Lab. Res., 26, 83-98.
27. + T cells. Annu. Rev. Immunol., 12, 635-673.
28. TRINCHIERI, G. (1998a). Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol., 70, 83-243.
29. TRINCHIERI, G. (1998b). Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol., 16, 365-396.
30. + T lymphocyte responses. Ann. N Y Acad. Sci., 795, 88-99.
31. VLIETINCK, A.J., DE BYNE, T., APERS, S. & PIETERS, L.A. (1998). Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med., 64, 97-109.